SOL SOLACI Performed a New Intervention During the Ecuador Sessions 2020

A new charitable case was featured at the Ecuador XL SOLACI Sessions 2020. At the CardioCentro Manta / Angiomanabí Clinic in Manta, Ecuador, physicians performed a successful closure of ductus arteriosus type A1 with an Amplatzer ADO I device (antegrade access). The patient was a 1-year old child admitted with a diagnosis of persistent ductus arteriosus. The case was sponsored by C.G MED.

Thus, SOLACI’s SOLidario (which means ‘solidary’ in Spanish) Program continues with its mission: facilitating the access to percutaneous and/or cardiovascular procedures to Latin American patients without the medical coverage or economic resources for them.

Below, the case presentation during the Ecuador Sessions 2020.

caso-solidario-jornadas-ecuador-2020

SOLACI’s SOLidario Program Against the COVID-19 Pandemic

Today, more than ever, the members of SOLACI’s SOLidario Program want our Latin American colleagues to know that we are in this together. As everyone knows, the primary purpose of this program is to grant our patients access to interventional procedures in renowned medical centers. Specialists who are SOLACI members perform such interventions in collaboration with other internationally famed experts.

The current situation would have been hard to imagine a short time ago. This pandemic represents an unimaginable challenge, but we will work together so that we can lead the resistance against the disease, directing our best efforts to aid those most vulnerable.

Dr. Marcelo Halac.
Head of SOLACI’s SOLidario Program.


About SOL SOLACI

programa solidario solaci

SOLACI’s SOLidario Program is a facilitator connecting the patient, the institution, the local scientific community, and the specialist with local suppliers in each country so that the performing team can count with the adequate supply of elements, drugs, and/or endovascular devices for a successful procedure.

Created by a group of adult and pediatric interventional cardiologists who are SOLACI members, SOLACI SOL seeks to facilitate the access to percutaneous therapeutic and diagnostic cardiovascular procedures, conducted in renowned medical centers by specialists who are SOLACI members, to patients in Latin America and the Caribbean who lack the medical coverage or economic resources for them.

In case of questions about SOLACI’s SOLidario Program, contact us at jornadas@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...